Requests: If you need specific information on this remedy - e.g. a proving or a case info on toxicology or whatsoever, please post a message in the Request area www.homeovision.org/forum/ so that all users may contribute.
Traditional Ayurvedic Uses:
The bark of the Terminalia arjuna tree has been used in Ayurvedic medicine for over 2500 years, primarily as a "cardiac tonic." Clinical research has indicated its usefulness in relieving anginal pain, and in the treatment of coronary artery disease, heart failure, and possibly hypercholesterolemia. It has also been found to be antibacterial and antimutagenic.
The bark is used in certain herbal combinations as a powerful, soothing tonic for the heart. It is good for both the physical heart as a muscle, as well as for the emotions associated with the heart.
Arjuna is used for loneliness, sadness and frustration. It strengthens the emotions to decrease excessive response to stress and trauma.
It helps strengthen the body's natural rejuvenative processes, hastening the replacement of dead or weak cells with fresh, vital ones.
In proper combinations, Arjuna helps stabilize an erratic heart beat.
Arjuna helps balance all three doshas at once (Vata, Pitta, Kapha), a rare and very valuable property.
On the ethnomedical significance of the Arjun tree, Terminalia arjuna (Roxb.) Wight & Arnot.
Kumar DS, Prabhakar YS.
Department of Physiology, International Institute of Ayurveda, Ramanathapuram, Coimbatore, India.
Terminalia arjuna is an important cardiotonic plant described in the Ayurveda, the ancient Indian medical science. It is also believed to have the ability to cure hepatic, urogenital, venereal and viral diseases. An attempt is made here to analyse the available drug recipes using this plant from Sanskrit literature in the light of modern scientific knowledge. The chemistry and pharmacology of T. arjuna are also discussed, and areas of future investigations are identified.
Homeopathyandmore, Ial_anar, Dec.6th, 2011:
Twelve patients with refractory chronic congestive heart failure (Class IV NYHA), related to idiopathic dilated cardiomyopathy (10 patients); previous myocardial infarction (one patient) and peripartum cardiomyopathy (one patient), received Terminalia Arjuna, an Indian medicinal plant, as bark extract (500 mg 8-hourly) or matching placebo for 2 weeks each, separated by 2 weeks washout period, in a double blind cross over design as an adjuvent to maximally tolerable conventional therapy (Phase I). The clinical, laboratory and echocardiographic evaluation was carried out at baseline and at the end of Terminalia Arjuna and placebo therapy and results were compared. Terminalia Arjuna, compared to placebo, was associated with improvement in symptoms and signs of heart failure, improvement in NYHA Class (Class III vs. Class IV), decrease in echo-left ventricular enddiastolic (125.28 +/- 27.91 vs. 134.56 +/- 29.71 ml/m2; P < 0.005) and endsystolic volume (81.06 +/- 24.60 vs. 94.10 +/- 26.42 ml/m2; P < 0.005) indices, increase in left ventricular stroke volume index (44.21 +/- 11.92 vs. 40.45 +/- 11.56 ml/m2; P < 0.05) and increase in left ventricular ejection fractions (35.33 +/- 7.85 vs. 30.24 +/- 7.13%; P < 0.005). On long term evaluation in an open design (Phase II), wherein Phase I participants continued Terminalia Arjuna in fixed dosage (500 mg 8-hourly) in addition to flexible diuretic, vasodilator and digitalis dosage for 20-28 months (mean 24 months) on outpatient basis, patients showed continued improvement in symptoms, signs, effort tolerance and NYHA Class, with improvement in quality of life